Trends in Shoulder Arthroplasty in Germany: A 10-Year Epidemiological Analysis of Patients with Primary Osteoarthritis of the Shoulder

• Published in: Healthcare (Basel) 2024-05, Vol.12 (9), p.949
• Main Authors: Hochberger, Felix Frederik, Herrmann, Philipp, Rudert, Maximilian, List, Kilian, Stratos, Ioannis
• Format: Article
• Language: English
• Subjects: age distribution; Age groups; Arthritis; Care and treatment; cuff-tear arthropathy; Forecasts and trends; healthcare data; Joint replacement surgery; Osteoarthritis; Patients; Prostheses; Regression analysis; reverse total shoulder arthroplasty; Rotator cuff; Shoulder; Shoulder replacement arthroplasty; Software; Trends
• ISSN: 2227-9032; 2227-9032
• DOI: 10.3390/healthcare12090949

Shoulder arthroplasty has significantly gained popularity in orthopedic surgery, driven by progress in prosthesis design and surgical techniques. This study explored the epidemiology of shoulder arthroplasty, analyzing healthcare data from 2012 to 2022 for primary osteoarthritis of the shoulder. The data included patient demographics and types of surgical procedures. Data analysis indicates a higher utilization rate of reverse total shoulder arthroplasty (RTSA; = 41,251) over total- (TSA; = 18,679) and hemiarthroplasty (HSA; = 12,827) for primary shoulder osteoarthritis. Overall, a significant increase in RTSA procedures from = 2237 (2012) to = 5415 (2022) was observed, representing more than a two-fold increase of 121.1%. The relative proportion of RTSA among all types of shoulder arthroplasty increased from 39% (2012) to 68.6% (2022), while HSA decreased and TSA essentially remained constant. Age analysis identified the following peaks: RTSA, 77 ± 7 y; HSA, 68 ± 12 y; and TSA, 67 ± 10 y. Among the over 60s, significantly more women were treated with any type of prosthesis, whereas in young patients (45 to 59 y), more men received HSA or TSA. Our study confirms that RTSA has become the preferred choice for elderly patients in Germany, reflecting the prevailing preference despite varying patient ages and conditions, with a noted difference in sex in treatment prevalence.